The myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It’s a dangerous misconception that has caused some people not to be diligent about ...

Fast Track status aims to accelerate development of an autologous dendritic cell immunotherapy for advanced cutaneous melanoma with limited durable benefit from current standards in many patients.

Not all melanomas are the same. They differ in presentation, mutational status, and behavior. Desmoplastic melanoma (DM) is a rare subtype of melanoma which carries a high tumor mutation burden and is ...

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...

Dermatologists are sounding the alarm about amelanotic melanoma, a rare skin cancer that lacks the dark pigmentation typically associated with melanoma. Often appearing pink, red, flesh-toned, or as a ...

Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is dropping, and how biomarkers are driving personalized care. Cutaneous melanoma ...

When Bad News Comes Through the Portal: Strengthening Trust and Guiding Patients When They Receive Bad Results Before Their Clinicians • We could advocate for policies and initiatives aimed at ...

This is read by an automated voice. Please report any issues or inconsistencies here. State-reported data in Arizona identified a massive detection gap: 215 melanomas in a year compared to the average ...

The myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It’s a dangerous misconception that has caused some people not to be diligent about ...